M&A Deal Summary |
|
|---|---|
| Date | 2016-11-21 |
| Target | Solon Eiendom AS |
| Sector | Real Estate |
| Buyer(s) | Solon Eiendom |
| Deal Type | Add-on Acquisition |
| Deal Value | 1.0B NOK |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Life Science |
| Employees | 49 |
| Revenue | 1.5B NOK (2020) |
Solon Eiendom is a developer of vaccines for human immunodeficiency virus, Hepatitis C and Influenza. Solon Eiendom was founded in 1993 and is based in Oslo, Norway.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Real Estate M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Norway M&A | 1 of 1 |
| Year: 2016 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |